Cargando…
Rituximab: Hypogammaglobulinaemia and recurrent COVID-19 infection: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853919/ http://dx.doi.org/10.1007/s40278-022-10400-5 |
Ejemplares similares
-
Recurrent COVID‐19 infection in a case of rituximab‐induced hypogammaglobulinaemia
por: Daniel, Jefferson, et al.
Publicado: (2021) -
Rituximab: Hypogammaglobulinaemia: 2 case reports
Publicado: (2021) -
Multiple drugs: Prolonged course of COVID 19 infection and hypogammaglobulinaemia: case report
Publicado: (2022) -
Tisagenlecleucel: Hypogammaglobulinaemia and pancytopenia: case report
Publicado: (2021) -
Bendamustine/remdesivir/rituximab: Lymphocytopenia, hypogammaglobulinaemia and rebound viral shedding following drug resistance: case report
Publicado: (2022)